Predictions
Cannabis Science Inc.
Start price
Target price
Perf. (%)
€0.097
25.01.17
25.01.17
€0.023
02.01.18
02.01.18
1.03%
02.01.18
02.01.18
General Cannabis Corp
Start price
Target price
Perf. (%)
€2.75
17.01.17
17.01.17
€1.00
16.05.17
16.05.17
-39.26%
16.05.17
16.05.17
Newmont Goldcorp Corp.
Start price
Target price
Perf. (%)
?31.94
30.12.16
30.12.16
€37.88
30.06.17
30.06.17
-8.25%
30.06.17
30.06.17
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€59.19
29.12.16
29.12.16
€94.71
21.06.17
21.06.17
60.00%
21.06.17
21.06.17
Berkshire Hathaway Inc. B
Start price
Target price
Perf. (%)
€156.84
13.12.16
13.12.16
€160.00
20.12.16
20.12.16
2.06%
20.12.16
20.12.16
Oracle Corp.
Start price
Target price
Perf. (%)
€34.93
01.12.16
01.12.16
€165.00
08.09.26
08.09.26
369.02%
04.10.24
04.10.24
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
High dividend yield expected
Micron Technology Inc.
Start price
Target price
Perf. (%)
€17.76
01.12.16
01.12.16
€18.83
01.12.16
01.12.16
-5.26%
01.12.16
01.12.16
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Undervalued
Low dividend yield expected
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€136.85
21.11.16
21.11.16
€150.00
21.02.17
21.02.17
10.28%
21.02.17
21.02.17
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€84.92
10.11.16
10.11.16
€108.24
10.05.17
10.05.17
-4.12%
10.05.17
10.05.17
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€71.74
10.11.16
10.11.16
€85.00
18.04.17
18.04.17
8.26%
18.04.17
18.04.17
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Melinta Therapeutics Inc.
Start price
Target price
Perf. (%)
€174.76
02.11.16
02.11.16
€405.90
02.05.17
02.05.17
-48.06%
02.05.17
02.05.17
Cannabis Sativa Inc.
Start price
Target price
Perf. (%)
€5.31
29.10.16
29.10.16
€8.00
19.01.17
19.01.17
56.15%
19.01.17
19.01.17
Chipotle Mexican Grill Inc.
Start price
Target price
Perf. (%)
€332.73
26.10.16
26.10.16
€432.96
19.04.17
19.04.17
30.48%
19.04.17
19.04.17
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.48
30.09.16
30.09.16
€98.00
08.09.26
08.09.26
35.57%
04.10.24
04.10.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued